-
Surface downmodulation of TIM3 safeguards healthy cells but not acute myeloid leukemia from CAR T-cell therapy
van der Schans, J. J., Vishwasrao, P., Poels, R., Antti, M., Wang, Z., Quik, M., van Arkel, J., Reuvekamp, T., van de Donk, N. W. C. J., Themeli, M., Ossenkoppele, G. J., van de Loosdrecht, A. A., Richards, R. & Mutis, T., 1 Jul 2025, In: HemaSphere. 9, 7, e70155.Research output: Contribution to journal › Article* › Academic › peer-review
-
A convenient viral transduction based method for advanced multi-engineering of primary human (CAR) T-cells
van der Schans, J. J., Katsarou, A., Kladis, G., Bar, C., Ramirez, M. M., Themeli, M. & Mutis, T., 1 Dec 2024, In: Journal of Genetic Engineering and Biotechnology. 22, 4, 100446.Research output: Contribution to journal › Article* › Academic › peer-review
-
Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138
van der Schans, J. J., Wang, Z., van Arkel, J., van Schaik, T., Katsarou, A., Ruiter, R., Baardemans, T., Yuan, H., de Bruijn, J., Zweegman, S., van de Donk, N. W. C. J., Groen, R. W. J., Themeli, M. & Mutis, T., 15 Oct 2023, In: Clinical cancer research : an official journal of the American Association for Cancer Research. 29, 20, p. 4219-4229 11 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
